696
Views
40
CrossRef citations to date
0
Altmetric
Review Article

UDP-glucuronosyltransferases (UGTs) in neuro-olfactory tissues: expression, regulation, and function

, , , , &
Pages 74-97 | Accepted 27 Jul 2009, Published online: 07 Oct 2009

References

  • ABA: The Allen Mouse Brain Atlas (ABA 2009; http://www.brain-map.org)
  • Albert, C., Barbier, O., Vallee, M., Beaudry, G., Belanger, A., Hum, D. W. (2000). Distribution of uridine diphosphate-glucuronosyltransferase (UGT) expression and activity in cynomolgus monkey tissues: evidence for differential expression of steroid-conjugating UGT enzymes in steroid target tissues. Endocrinology 141:2472–2480.
  • Anderson, G. D. (2008). Gender differences in pharmacological response. Int Rev Neurobiol 83:1–10.
  • Barbier, O., Girard, C., Breton, R., Belanger, A., Hum, D. W. (2000). N-glycosylation and residue 96 are involved in the functional properties of UDP-glucuronosyltransferase enzymes. Biochemistry 39:11540–11552.
  • Barbier, O., Trottier, J., Kaeding, J., Caron, P., Verreault, M. (2009). Lipid-activated transcription factors control bile acid glucuronidation. Mol Cell Biochem 326:3–8.
  • Barret, A., Forestier, L., Deslys, J. P., Julien, R., Gallet, P. F. (2005). Glycosylation-related gene expression in prion diseases: PrPSc accumulation in scrapie infected GT1 cells depends on beta-1,4-linked GalNAc-4-SO4 hyposulfation. J Biol Chem 280:10516–10523.
  • Basu, N. K., Kole, L., Basu, M., Chakraborty, K., Mitra, P. S., Owens, I.S. (2008). The major chemical-detoxifying system of UDP-glucuronosyltransferases requires regulated phosphorylation supported by protein kinase C. J Biol Chem 283:23048–23061.
  • Bayer, S. A. (1983). 3H-thymidine-radiographic studies of neurogenesis in the rat olfactory bulb. Exp Brain Res 50:329–340.
  • Belyanskaya, L., Weigel, S., Hirsch, C., Tobler, U., Krug, H.F., Wick P. (2009). Effects of carbon nanotubes on primary neurons and glial cells. Neurotoxicology 30:497–521. [Epub 2009 Mar 24].
  • Ben-Arie, N., Khen, M., Lancet, D. (1993). Glutathione S-transferases in rat olfactory epithelium: purification, molecular properties, and odorant biotransformation. Biochem J 292(Pt 2):379–384.
  • Berkowicz, D. A., Trombley, P. Q. (2000). Dopaminergic modulation at the olfactory nerve synapse. Brain Res 855:90–99.
  • Bhasker, C. R., McKinnon, W., Stone, A., Lo, A. C., Kubota, T., Ishizaki, T., et al. (2000). Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance. Pharmacogenetics 10:679–685.
  • Bjorkhem, I., Andersson, U., Ellis, E., Alvelius, G., Ellegard, L., Diczfalusy, U., et al. (2001). From brain to bile. Evidence that conjugation and omega-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans. J Biol Chem 276:37004–37010.
  • Bjorkhem, I., Eggertsen, G. (2001). Genes involved in initial steps of bile acid synthesis. Curr Opin Lipidol 12:97–103.
  • Bock, K. W., Kohle, C. (2005). UDP-glucuronosyltransferase 1A6: structural, functional, and regulatory aspects. Meth Enzymol 400:57–75.
  • Bond, J. A. (1983). Some biotransformation enzymes responsible for polycyclic aromatic hydrocarbon metabolism in rat nasal turbinates: effects on enzyme activities of in vitro modifiers and intraperitoneal and inhalation exposure of rats to inducing agents. Cancer Res 43:4805–4811.
  • Bookout, A. L., Jeong, Y., Downes, M., Yu, R. T., Evans, R. M., Mangelsdorf, D. J. (2006). Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126:789–799.
  • Bosio, A., Binczek, E., Le Beau M.M., Fernald, A.A., Stoffel, W. (1996). The human gene CGT encoding the UDP-galactose ceramide galactosyl transferase (cerebroside synthase): cloning, characterization, and assignment to human chromosome 4, band q26. Genomics 34:69–75.
  • Bosma, P. J., Goldhoorn, B., Oude Elferink, R. P., Sinaasappel, M., Oostra, B. A., Jansen, P.L. (1993). A mutation in bilirubin uridine 5’-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II. Gastroenterology 105:216–220.
  • Bosma, P. J., Seppen, J., Goldhoorn, B., Bakker, C., Oude Elferink, R. P., Chowdhury, J. R., et al. (1994). Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 269:17960–17964.
  • Brittebo, E. B. (1993). Metabolism of xenobiotics in the nasal olfactory mucosa: implications for local toxicity. Pharmacol Toxicol 72(Suppl 3):50–52.
  • Buck, L., Axel, R. (1991). A novel multigene family may encode odorant receptors: a molecular basis for odor recognition. Cell 65:175–187.
  • Buck, L. B. (2005). Unraveling the sense of smell (Nobel lecture). Angew Chem Int Ed Engl 44:6128–6140.
  • Buckley, D. B., Klaassen, C. D. (2007). Tissue- and gender-specific mRNA expression of UDP-glucuronosyltransferases (UGTs) in mice. Drug Metab Dispos 35:121–127.
  • Buckley, D. B., Klaassen, C. D. (2009a). Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane × receptor, peroxisome proliferator-activated receptor alpha, and nuclear factor erythroid 2-related factor 2. Drug Metab Dispos 37:847–856.
  • Buckley, D. B., Klaassen, C. D. (2009b). Mechanism of gender-divergent UDP-glucuronosyltransferase mRNA expression in mouse liver and kidney. Drug Metab Dispos 37:834–840.
  • Caillier, B., Lepine, J., Tojcic, J., Menard, V., Perusse, L., Belanger, A., et al. (2007). A pharmacogenomics study of the human estrogen glucuronosyltransferase UGT1A3. Pharmacogenet Genom 17:481–495.
  • Calderon, F., Kim, H. Y. (2004). Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J Neurochem 90:979–988.
  • Catania, V. A., Dannenberg, A. J., Luquita, M. G., Sanchez Pozzi, E. J., Tucker, J. K., Yang, E. K., et al. (1995). Gender-related differences in the amount and functional state of rat liver UDP-glucuronosyltransferase. Biochem Pharmacol 50:509–514.
  • Charlier, T. D., Balthazart, J. (2005). Modulation of hormonal signaling in the brain by steroid receptor coactivators. Rev Neurosci 16:339–357.
  • Chat, M., Bayol-Denizot, C., Suleman, G., Roux, F., Minn, A. (1998). Drug metabolizing enzyme activities and superoxide formation in primary and immortalized rat brain endothelial cells. Life Sci 62:151–163.
  • Chen, J., Tu, Y., Moon, C., Nagata, E., Ronnett, G. V. (2003). Heme oxygenase-1 and heme oxygenase-2 have distinct roles in the proliferation and survival of olfactory receptor neurons mediated by cGMP and bilirubin, respectively. J Neurochem 85:1247–1261.
  • Chen, S., Beaton, D., Nguyen, N., Senekeo-Effenberger, K., Brace-Sinnokrak, E., Argikar, U., et al. (2005). Tissue-specific, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus. J Biol Chem 280:37547–37557.
  • Chowdhury, J. R., Kondapalli, R., Chowdhury, N. R. (1993). Gunn rat: a model for inherited deficiency of bilirubin glucuronidation. Adv Vet Sci Comp Med 37:149–173.
  • Christrup, L. L. (1997). Morphine metabolites. Acta Anaesthesiol Scand 41:116–122.
  • Ciotti, M., Marrone, A., Potter, C., Owens, I. S. (1997). Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications. Pharmacogenetics 7:485–495.
  • Coffman, B. L., Rios, G. R., King, C. D., Tephly, T. R. (1997). Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos 25:1–4.
  • Court, M. H. (2005). Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases. Meth Enzymol 400:104–116.
  • Court, M. H., Hazarika, S., Krishnaswamy, S., Finel, M., Williams, J. A. (2008). Novel polymorphic human UDP-glucuronosyltransferase 2A3: cloning, functional characterization of enzyme variants, comparative tissue expression, and gene induction. Mol Pharmacol 74:744–754.
  • Dahlin, A., Royall, J., Hohmann, J. G., Wang, J. (2009). Expression profiling of the solute carrier gene family in the mouse brain. J Pharmacol Exp Ther 329:558–570.
  • Daidoji, T., Gozu, K., Iwano, H., Inoue, H., Yokota, H. (2005). UDP-glucuronosyltransferase isoforms catalyzing glucuronidation of hydroxy-polychlorinated biphenyls in rat. Drug Metab Dispos 33:1466–1476.
  • Danielyan, L., Schafer, R., von Ameln-Mayerhofer, A., Buadze, M., Geisler, J., Klopfer, T., et al. (2009). Intranasal delivery of cells to the brain. Eur J Cell Biol 88:315–324.
  • Das, U. N. (2006). Essential Fatty acids—a review. Curr Pharm Biotechnol 7:467–482.
  • Davies, D. C., Brooks, J. W. and Lewis, D. A. (1993). Axonal loss from the olfactory tracks in Alzhelmer’s disease. Neurobiol Aging. 14:353–357.
  • Davila, N. G., Blakemore, L. J., Trombley, P. Q. (2003). Dopamine modulates synaptic transmission between rat olfactory bulb neurons in culture. J Neurophysiol 90:395–404.
  • De Leon, J. (2003). Glucuronidation enzymes, genes, and psychiatry. Int J Neuropsychopharmacol 6:57–72.
  • de Zwart, L., Scholten, M., Monbaliu, J. G., Annaert, P. P., Van Houdt, J. M., Van den Wyngaert, I., et al. (2008). The ontogeny of drug metabolizing enzymes and transporters in the rat. Reprod Toxicol 26:220–230.
  • Dehay, C., Kennedy, H. (2009). Transcriptional regulation and alternative splicing make for better brains. Neuron 62:455–457.
  • Dietschy, J. M. (2009). Central nervous system: cholesterol turnover, brain development, and neurodegeneration. Biol Chem 390:287–293.
  • Dietschy, J. M., Turley, S. D. (2004). Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45:1375–1397.
  • Ding, X., Dahl, A. R. (2003) Olfactory mucosa: composition, enzymatic localization, and metabolism. In: Doty, R. L. (Ed.), Handbook of olfaction and gustation, 2nd ed. (pp 51–73). New York: Marcel Dekker, Inc.
  • Ding, X. X., Porter, T. D., Peng, H. M., Coon, M. J. (1991). cDNA and derived amino acid sequence of rabbit nasal cytochrome P450NMb (P450IIG1), a unique isozyme possibly involved in olfaction. Arch Biochem Biophys 285:120–125.
  • Dore, S., Takahashi, M., Ferris, C. D., Zakhary, R., Hester, L. D., Guastella, D., et al. (1999). Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci U S A 96:2445–2450.
  • Doty, R. L., Reyes, P. F. and Gregar, T. (1987). Presence of both odor identification and detection deficits in Alzheimer’s disease. Brain Res Bull. 18:597–600.
  • Doty, R. L. (2008). The olfactory vector hypothesis of neurodegenerative disease: is it viable? Ann Neurol 63:7–15.
  • du Bois, T. M., Deng, C., Huang, X. F. (2005). Membrane phospholipid composition, alterations in neurotransmitter systems, and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29:878–888.
  • Duguay, Y., Baar, C., Skorpen, F., Guillemette, C. (2004). A novel functional polymorphism in the uridine diphosphate-glucuronosyltransferase 2B7 promoter with significant impact on promoter activity. Clin Pharmacol Ther 75:223–233.
  • Dutheil, F., Beaune, P., Loriot, M. A. (2008). Xenobiotic metabolizing enzymes in the central nervous system: contribution of cytochrome P450 enzymes in normal and pathological human brain. Biochimie 90:426–436.
  • Ehmer, U., Vogel, A., Schutte, J. K., Krone, B., Manns, M. P., Strassburg, C. P. (2004). Variation of hepatic glucuronidation: novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4. Hepatology 39:970–977.
  • Ferreyra-Moyano, H., Barragan, E. (1989). The olfactory system and Alzheimer’s disease. Int J Neurosci 49:157–197.
  • Finel, M., Kurkela, M. (2008). The UDP-glucuronosyltransferases as oligomeric enzymes. Curr Drug Metab 9:70–76.
  • Fong, K. J., Kern, R. C., Foster, J. D., Zhao, J. C., Pitovski, D. Z. (1999). Olfactory secretion and sodium, potassium-adenosine triphosphatase: regulation by corticosteroids. Laryngoscope 109:383–388.
  • Frances, B., Gout, R., Monsarrat, B., Cros, J., Zajac, J. M. (1992). Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine. J Pharmacol Exp Ther 262:25–31.
  • Fricchione, G., Zhu, W., Cadet, P., Mantione, K. J., Bromfield, E., Madsen, J., et al. (2008). Identification of endogenous morphine and a mu3-like opiate alkaloid receptor in human brain tissue taken from a patient with intractable complex partial epilepsy. Med Sci Monit 14:CS45–CS49.
  • Gage, F. H. (2002). Neurogenesis in the adult brain. J Neurosci 22:612–613.
  • Gardner-Stephen, D. A., Mackenzie, P. I. (2008). Liver-enriched transcription factors and their role in regulating UDP-glucuronosyltransferase gene expression. Curr Drug Metab 9:439–452.
  • Gerozissis, K. (2008). Brain insulin, energy, and glucose homeostasis; genes, environment, and metabolic pathologies. Eur J Pharmacol 585:38–49.
  • Getchell, T. V., Margolis, F. L., Getchell, M. L. (1984). Perireceptor and receptor events in vertebrate olfaction. Prog Neurobiol 23:317–345.
  • Ghersi-Egea, J. F., Leininger-Muller, B., Minn, A., Siest, G. (1992). Drug metabolizing enzymes in the rat pituitary gland. Prog Brain Res 91:373–378.
  • Ghersi-Egea, J. F., Leninger-Muller, B., Suleman, G., Siest, G., Minn, A. (1994). Localization of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs. J Neurochem 62:1089–1096.
  • Ghersi-Egea, J. F., Minn, A., Siest, G. (1988). A new aspect of the protective functions of the blood-brain barrier: activities of four drug-metabolizing enzymes in isolated rat brain microvessels. Life Sci 42:2515–2523.
  • Ghersi-Egea, J. F., Perrin, R., Leininger-Muller, B., Grassiot, M. C., Jeandel, C., Floquet, J., et al. (1993). Subcellular localization of cytochrome P450, and activities of several enzymes responsible for drug metabolism in the human brain. Biochem Pharmacol 45:647–658.
  • Ghersi-Egea, J. F., Walther, B., Decolin, D., Minn, A., Siest, G. (1987). The activity of 1-naphthol-UDP-glucuronosyltransferase in the brain. Neuropharmacology 26:367–372.
  • Gofflot, F., Chartoire, N., Vasseur, L., Heikkinen, S., Dembele, D., Le Merrer, J., et al. (2007). Systematic gene expression mapping clusters nuclear receptors according to their function in the brain. Cell 131:405–418.
  • Goswami, S. K., Das, D. K. (2009). Resveratrol and chemoprevention. Cancer Lett 284:1–6. [Epub 2009 Mar 3].
  • Gradinaru, D., Minn, A. L., Artur, Y., Minn, A., Heydel, J. M. (2009). Drug metabolizing enzyme expression in rat choroid plexus: effects of in vivo xenobiotics treatment. Arch Toxicol 83:581–586.
  • Gradinaru, D., Suleman, F. G., Leclerc, S., Heydel, J. M., Grillasca, J. P., Magdalou, J., Minn, A. (1999). UDP-glucuronosyltransferase in the rat olfactory bulb: identification of the UGT1A6 isoform and age-related changes in 1-naphthol glucuronidation. Neurochem Res 24:995–1000.
  • Graff, C. L., Pollack, G. M. (2004). Drug transport at the blood-brain barrier and the choroid plexus. Curr Drug Metab 5:95–108.
  • Grunewald, S., Matthijs, G. (2000). Congenital disorders of glycosylation (CDG): a rapidly expanding group of neurometabolic disorders. Neuropediatrics 31:57–59.
  • Guevara, J., Espinosa, B., Zenteno, E., Vazguez, L., Luna, J., Perry, G., et al. (1998). Altered glycosylation pattern of proteins in Alzheimer’s disease. J Neuropathol Exp Neurol 57:905–914.
  • Haberly, L. B. (2001). Parallel-distributed processing in olfactory cortex: new insights from morphological and physiological analysis of neuronal circuitry. Chem Senses 26:551–576.
  • Hagglund, M., Berghard, A., Strotmann, J., Bohm, S. (2006). Retinoic acid receptor-dependent survival of olfactory sensory neurons in postnatal and adult mice. J Neurosci 26:3281–3291.
  • Haining, R. L., Nichols-Haining, M. (2007). Cytochrome P450–catalyzed pathways in human brain: metabolism meets pharmacology or old drugs with new mechanism of action? Pharmacol Ther 113:537–545.
  • Hanson, L. R., Frey, W. H., 2nd. (2008). Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci 9(Suppl 3):S5.
  • Henry, L. A., Witt, D. M. (2002). Resveratrol: phytoestrogen effects on reproductive physiology and behavior in female rats. Horm Behav 41:220–228.
  • Heurtaux, T., Benani, A., Bianchi, A., Moindrot, A., Gradinaru, D., Magdalou, J., et al. (2004). Redox state alteration modulates astrocyte glucuronidation. Free Radic Biol Med 37:1051–1063.
  • Heurtaux, T., Benani, A., Moulin, D., Muller, N., Netter, P., Minn, A. (2006). Induction of UGT1A6 isoform by inflammatory conditions in rat astrocytes. Neuropharmacology 50:317–328.
  • Heydel, J., Leclerc, S., Bernard, P., Pelczar, H., Gradinaru, D., Magdalou, J., et al. (2001). Rat olfactory bulb and epithelium UDP-glucuronosyltransferase 2A1 (UGT2A1) expression: in situ mRNA localization and quantitative analysis. Brain Res Mol Brain Res 90:83–92.
  • Hilger, P. A. (1989). Applied anatomy and physiology of the nose. In: Adams, G. L., Boies, L., Hilger, P. A. (Eds.), Fundamentals of otolaryngology. A textbook of ear, nose and throat diseases (pp. 177–195). Philadelphia, Pennsylvania, USA: W.B.Saunders.
  • Hook, G. E., Haseman, J. K., Lucier, G. W. (1975). Induction and suppression of hepatic and extrahepatic microsomal foreign-compound-metabolizing enzyme systems by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Chem Biol Interact 10:199–214.
  • Huang, Y. H., Galijatovic, A., Nguyen, N., Geske, D., Beaton, D., Green, J., et al. (2002). Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2, and UGT1A8*3. Pharmacogenetics 12:287–297.
  • Iida, A., Saito, S., Sekine, A., Mishima, C., Kitamura, Y., Kondo, K., et al. (2002). Catalog of 86 single-nucleotide polymorphisms (SNPs) in three uridine diphosphate glycosyltransferase genes: UGT2A1, UGT2B15, and UGT8. J Hum Genet 47:505–510.
  • Illum, L. (2000). Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 11:1–18.
  • Illum, L. (2004). Is nose-to-brain transport of drugs in man a reality? J Pharm Pharmacol 56:3–17.
  • Ingebrigtsen, K., Hektoen, H., Andersson, T., Klasson Wehler, E., Bergman, A., Brandt, I. (1992). Enrichment of metabolites in the cerebrospinal fluid of cod (Gadus morhua) following oral administration of hexachlorobenzene and 2,4’,5-trichlorobiphenyl. Pharmacol Toxicol 71:420–425.
  • Iolascon, A., Perrotta, S., Coppola, B., Carbone, R., Miraglia Del Giudice E. (2000). Frequency of Gilbert’s syndrome associated with UGTA1 (TA)(7) polymorphism in Southern Italy. Haematologica 85:335–336.
  • Ishii, H., Tsurugizawa, T., Ogiue-Ikeda, M., Asashima, M., Mukai, H., Murakami, G., et al. (2007). Local production of sex hormones and their modulation of hippocampal synaptic plasticity. Neuroscientist 13:323–334.
  • Itaaho, K., Mackenzie, P. I., Ikushiro, S., Miners, J. O., Finel, M. (2008). The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases. Drug Metab Dispos 36:2307–2315.
  • Iwai, M., Maruo, Y., Ito, M., Yamamoto, K., Sato, H., Takeuchi, Y. (2004). Six novel UDP-glucuronosyltransferase (UGT1A3) polymorphisms with varying activity. J Hum Genet 49:123–128.
  • Jacobson, J. L., Jacobson, S. W. (1997). Evidence for PCBs as neurodevelopmental toxicants in humans. Neurotoxicology 18:415–424.
  • Jacobson, J. L., Jacobson, S. W., Humphrey, H. E. (1990). Effects of in utero exposure to polychlorinated biphenyls and related contaminants on cognitive functioning in young children. J Pediatr 116:38–45.
  • Jedlitschky, G., Cassidy, A. J., Sales, M., Pratt, N., Burchell, B. (1999). Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase. Biochem J 340(Pt 3):837–843.
  • Kapitonov, D., Yu, R. K. (1997). Cloning, characterization, and expression of human ceramide galactosyltransferase cDNA. Biochem Biophys Res Commun 232:449–453.
  • Kapitulnik, J. (2004). Bilirubin: an endogenous product of heme degradation with both cytotoxic and cytoprotective properties. Mol Pharmacol 66:773–779.
  • Keller, A., Zhuang, H., Chi, Q., Vosshall, L. B., Matsunami, H. (2007). Genetic variation in a human odorant receptor alters odour perception. Nature 449:468–472.
  • King, C. D., Rios, G. R., Assouline, J. A., Tephly, T. R. (1999). Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate. Arch Biochem Biophys 365:156–162.
  • King, S. R. (2008). Emerging roles for neurosteroids in sexual behavior and function. J Androl 29:524–533.
  • Kurosaki, M., Terao, M., Barzago, M. M., Bastone, A., Bernardinello, D., Salmona, M., et al. (2004). The aldehyde oxidase gene cluster in mice and rats. Aldehyde oxidase homologue 3, a novel member of the molybdo-flavoenzyme family with selective expression in the olfactory mucosa. J Biol Chem 279:50482–50498.
  • Lambert, J. G., Resink, J. W. (1991). Steroid glucuronides as male pheromones in the reproduction of the African catfish, Clarias gariepinus—a brief review. J Steroid Biochem Mol Biol 40:549–556.
  • Lampe, J. W., Bigler, J., Bush, A. C., Potter, J. D. (2000). Prevalence of polymorphisms in the human UDP-glucuronosyltransferase 2B family: UGT2B4(D458E), UGT2B7(H268Y), and UGT2B15(D85Y). Cancer Epidemiol Biomarkers Prev 9:329–333.
  • Lazard, D., Tal, N., Rubinstein, M., Khen, M., Lancet, D., Zupko, K. (1990). Identification and biochemical analysis of novel olfactory-specific cytochrome P-450IIA and UDP-glucuronosyl transferase. Biochemistry 29:7433–7440.
  • Lazard, D., Zupko, K., Poria, Y., Nef, P., Lazarovits, J., Horn, S., et al. (1991). Odorant signal termination by olfactory UDP-glucuronosyl transferase. Nature 349:790–793.
  • Leclerc, S., Heydel, J. M., Amosse, V., Gradinaru, D., Cattarelli, M., Artur, Y., et al. (2002). Glucuronidation of odorant molecules in the rat olfactory system: activity, expression, and age-linked modifications of UDP-glucuronosyltransferase isoforms, UGT1A6 and UGT2A1, and relation to mitral cell activity. Brain Res Mol Brain Res 107:201–213.
  • Lee, C. H., Mo, J. H., Shim, S. H., Ahn, J. M., Kim, J. W. (2008). Effect of ginkgo biloba and dexamethasone in the treatment of 3-methylindole-induced anosmia mouse model. Am J Rhinol 22:292–296.
  • Lein, E. S. Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., et al. (2007). Genome-wide atlas of gene expression in the adult mouse brain. Nature 445:168–176.
  • Leininger, B., Ghersi-Egea, J. F., Siest, G., Minn, A. (1991). In vivo study of the elimination from rat brain of an intracerebrally formed xenobiotic metabolite, 1-naphthyl-beta-D-glucuronide. J Neurochem 56:1163–1168.
  • Leininger-Muller, B., Ghersi-Egea, J. F., Siest, G., Minn, A. (1994). Induction and immunological characterization of the uridine diphosphate-glucuronosyltransferase conjugating 1-naphthol in the rat choroid plexus. Neurosci Lett 175:37–40.
  • Levesque, E., Beaulieu, M., Green, M. D., Tephly, T. R., Belanger, A., Hum, D. W. (1997). Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 7:317–325.
  • Lim, Y. P., Huang, J. D. (2008). Interplay of pregnane × receptor with other nuclear receptors on gene regulation. Drug Metab Pharmacokinet 23:14–21.
  • Little, J. M., Kurkela, M., Sonka, J., Jantti, S., Ketola, R., Bratton, S., et al. (2004). Glucuronidation of oxidized fatty acids and prostaglandins B1 and E2 by human hepatic and recombinant UDP-glucuronosyltransferases. J Lipid Res 45:1694–1703.
  • Little, J. M., Williams, L., Xu, J., Radominska-Pandya, A. (2002). Glucuronidation of the dietary fatty acids, phytanic acid, and docosahexaenoic acid, by human UDP-glucuronosyltransferases. Drug Metab Dispos 30:531–533.
  • Liu, Z., Kim, J., Sypek, J. P., Wang, I. M., Horton, H., Oppenheim, F. G., et al. (2004). Gene expression profiles in human nasal polyp tissues studied by means of DNA microarray. J Allergy Clin Immunol 114:783–790.
  • Longo, V., Citti, L., Gervasi, P. G. (1988). Biotransformation enzymes in nasal mucosa and liver of Sprague-Dawley rats. Toxicol Lett 44:289–297.
  • Lu, Y., Bratton, S., Heydel, J. M., Radominska-Pandya, A. (2008). Effect of retinoids on UDP-glucuronosyltransferase 2B7 mRNA expression in Caco-2 cells. Drug Metab Pharmacokinet 23:364–372.
  • Lu, Y., Heydel, J. M., Li, X., Bratton, S., Lindblom, T., Radominska-Pandya, A. (2005). Lithocholic acid decreases expression of UGT2B7 in Caco-2 cells: a potential role for a negative farnesoid × receptor response element. Drug Metab Dispos 33:937–946.
  • Lutjohann, D. (2006). Cholesterol metabolism in the brain: importance of 24S-hydroxylation. Acta Neurol Scand Suppl 185:33–42.
  • Mackenzie, P. I., Bock, K. W., Burchell, B., Guillemette, C., Ikushiro, S., Iyanagi, T., et al. (2005). Nomenclature update for the mammalian UDP-glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genom 15:677–685.
  • Mackenzie, P. I., Gregory, P. A., Gardner-Stephen, D. A., Lewinsky, R. H., Jorgensen, B. R., Nishiyama, T., et al. (2003). Regulation of UDP-glucuronosyltransferase genes. Curr Drug Metab 4:249–257.
  • Mackenzie, P. L., Rogers, A., Treloar, J., Jorgensen, B.R., Miners, J. O. and Meech, R. (2008).. Identification of UDP glycosyl transferase 3A1 as a UDP N-acetylglucosaminyl transferase. J Biol Chem. 283:36205–36210.
  • Maden, M. (2007). Retinoic acid in the development, regeneration, and maintenance of the nervous system. Nat Rev Neurosci 8:755–765.
  • Mahboob, M., Kaleem, M., Siddiqui, J. (2004). Effects of a novel organophosphorus pesticide (RPR-V) on extra hepatic detoxifying enzymes after repeated oral doses in rats. Toxicology 202:159–164.
  • Mahboob, M., Siddiqui, M. K. (2002). Long-term effects of a novel phosphorothionate (RPR-II) on detoxifying enzymes in brain, lung, and kidney rats. Ecotoxicol Environ Saf 53:355–360.
  • Maibeche-Coisne, M., Merlin, C., Francois, M. C., Porcheron, P., Jacquin-Joly, E. (2005). P450 and P450 reductase cDNAs from the moth, Mamestra brassicae: cloning and expression patterns in male antennae. Gene 346:195–203.
  • Maibeche-Coisne, M., Nikonov, A. A., Ishida, Y., Jacquin-Joly, E., Leal, W. S. (2004). Pheromone anosmia in a scarab beetle induced by in vivo inhibition of a pheromone-degrading enzyme. Proc Natl Acad Sci U S A 101:11459–11464.
  • Mano, N., Goto, T., Uchida, M., Nishimura, K., Ando, M., Kobayashi, N., et al. (2004a). Presence of protein-bound unconjugated bile acids in the cytoplasmic fraction of rat brain. J Lipid Res 45:295–300.
  • Mano, N., Sato, Y., Nagata, M., Goto, T., Goto, J. (2004b). Bioconversion of 3-beta-hydroxy-5-cholenoic acid into chenodeoxycholic acid by rat brain enzyme systems. J Lipid Res 45:1741–1748.
  • Martinasevic, M. K., King, C. D., Rios, G. R. and Tephly, T. R. (1998). Immunochistochemical localization of UDP-glucuronosyl transferases in rat brain during early development. Drug Metab Dispos. 26:1039–1041.
  • Mayer, U., Ungerer, N., Klimmeck, D., Warnken, U., Schnolzer, M., Frings, S., et al. (2008). Proteomic analysis of a membrane preparation from rat olfactory sensory cilia. Chem Senses 33:145–162.
  • Meech, R., Mackenzie, P. I. (1997). Structure and function of uridine diphosphate glucuronosyltransferases. Clin Exp Pharmacol Physiol 24:907–915.
  • Mendez-Otero, R., Zaverucha-do-Valle, C., Gubert, F., Freitas, G. R., Santiago, M. F. (2005). Regulation and function of neurogenesis in the adult vertebrate brain. Braz J Med Biol Res 38:1553–1559.
  • Merkus, F. W., van den Berg, M. P. (2007). Can nasal drug delivery bypass the blood-brain barrier?: questioning the direct transport theory. Drugs R D 8:133–144.
  • Merlin, C., Francois, M. C., Bozzolan, F., Pelletier, J., Jacquin-Joly, E., Maibeche-Coisne, M. (2005). A new aldehyde oxidase selectively expressed in chemosensory organs of insects. Biochem Biophys Res Commun 332:4–10.
  • Minn, A., Ghersi-Egea, J. F., Perrin, R., Leininger, B., Siest, G. (1991). Drug metabolizing enzymes in the brain and cerebral microvessels. Brain Res Brain Res Rev 16:65–82.
  • Minn, A., Leclerc, S., Heydel, J. M., Minn, A. L., Denizcot, C., Cattarelli, M., et al. (2002). Drug transport into the mammalian brain: the nasal pathway and its specific metabolic barrier. J Drug Targ 10:285–296.
  • Minn, A. L., Pelczar, H., Denizot, C., Martinet, M., Heydel, J. M., Walther, B., et al. (2005). Characterization of microsomal cytochrome P450–dependent monooxygenases in the rat olfactory mucosa. Drug Metab Dispos 33:1229–1237.
  • Misiti, S., Koibuchi, N., Bei, M., Farsetti, A., Chin, W. W. (1999). Expression of steroid receptor coactivator-1 mRNA in the developing mouse embryo: a possible role in olfactory epithelium development. Endocrinology 140:1957–1960.
  • Miyawaki, A., Homma, H., Tamura, H., Matsui, M., Mikoshiba, K. (1996). Zonal distribution of sulfotransferase for phenol in olfactory sustentacular cells. Embo J 15:2050–2055.
  • Moffatt, C. A. (2003). Steroid hormone modulation of olfactory processing in the context of sociosexual behaviors in rodents and humans. Brain Res Brain Res Rev 43:192–206.
  • Monte, J. C., Nagle, M. A., Eraly, S. A., Nigam, S. K. (2004). Identification of a novel murine organic anion transporter family member, OAT6, expressed in olfactory mucosa. Biochem Biophys Res Commun 323:429–436.
  • Mori, K., Nagao, H.,Yoshihara, Y. (1999). The olfactory bulb: coding and processing of odor molecule information. Science 286:711–715.
  • Muller, A., Glattard, E., Taleb, O., Kemmel, V., Laux, A., Miehe, M., et al. (2008). Endogenous morphine in SH-SY5Y cells and the mouse cerebellum. PLoS ONE 3:e1641.
  • Nagano, E., Yamada, H., Oguri, K. (2000). Characteristic glucuronidation pattern of physiologic concentration of morphine in rat brain. Life Sci 67:2453–2464.
  • Nef, P., Heldman, J., Lazard, D., Margalit, T., Jaye, M., Hanukoglu, I., et al. (1989). Olfactory-specific cytochrome P-450. cDNA cloning of a novel neuroepithelial enzyme possibly involved in chemoreception. J Biol Chem 264:6780–6785.
  • Neri, C., Ghelardini, C., Sotak, B., Palmiter, R. D., Guarna, M., Stefano, G., et al. (2008). Dopamine is necessary to endogenous morphine formation in mammalian brain in vivo. J Neurochem 106:2337–2344.
  • Neri, C., Guarna, M., Bianchi, E., Sonetti, D., Matteucci, G., Stefano, G. B. (2004). Endogenous morphine and codeine in the brain of non human primate. Med Sci Monit 10:MS1–MS5.
  • Nguyen, N., Bonzo, J. A., Chen, S., Chouinard, S., Kelner, M. J., Hardiman, G., et al. (2008). Disruption of the ugt1 locus in mice resembles human Crigler-Najjar type I disease. J Biol Chem 283:7901–7911.
  • Norlin, M., Wikvall, K. (2007). Enzymes in the conversion of cholesterol into bile acids. Curr Mol Med 7:199–218.
  • Ohno, S., Kawana, K., Nakajin, S. (2008). Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic properties. Drug Metab Dispos 36:688–694.
  • Operana, T. N., Tukey, R. H. (2007). Oligomerization of the UDP-glucuronosyltransferase 1A proteins: homo- and heterodimerization analysis by fluorescence resonance energy transfer and coimmunoprecipitation. J Biol Chem 282:4821–4829.
  • Osborne, R., Joel, S., Trew, D., Slevin, M. (1990). Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide. Clin Pharmacol Ther 47:12–19.
  • Pause, B. M. (2004). Are androgen steroids acting as pheromones in humans? Physiol Behav 83:21–29.
  • Persidsky, Y., Ramirez, S. H., Haorah, J., Kanmogne, G. D. (2006). Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 1:223–236.
  • Petzold, G. C., Hagiwara, A., Murthy, V. N. (2009). Serotonergic modulation of odor input to the mammalian olfactory bulb. Nat Neurosci [Epub 2009 Aug 11].
  • Pignatelli, A., Kobayashi, K., Okano, H., Belluzzi, O. (2005). Functional properties of dopaminergic neurones in the mouse olfactory bulb. J Physiol 564:501–514.
  • Pompeiano, M., Palacios, J. M., Mengod, G. (1994). Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res Mol Brain Res 23:163–178.
  • Radominska-Pandya, A., Bratton, S., Little, J. M. (2005). A historical overview of the heterologous expression of mammalian UDP-glucuronosyltransferase isoforms over the past twenty years. Curr Drug Metab 6:141–160.
  • Radominska-Pandya, A., Czernik, P. J., Little, J. M., Battaglia, E., Mackenzie, P. I. (1999). Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab Rev 31:817–899.
  • Rogers, M. E., Jani, M. K., Vogt, R. G. (1999). An olfactory-specific glutathione-S-transferase in the sphinx moth, Manduca sexta. J Exp Biol 202:1625–1637.
  • Rosen, G. D., La Porte, N. T., Diechtiareff, B., Pung, C. J., Nissanov, J., Gustafson, C., Bertrand, L., Gefen, S., Fan, Y., Tretiak, O. J., Manly, K. F., Park, M. R., Williams, A. G., Connolly, M. T., Capra, J. A. and Williams, R. W. (2003).. Informatics center for mouse genomics: the dissection of complex traits of the nervous system. Neuroinformatics. 1:327–342.
  • Rosenfeld, M. G., Lunyak, V. V., Glass, C. K. (2006). Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 20:1405–1428.
  • Roy-Chowdhury, J., Locker, J., Roy-Chowdhury, N. (2003). Nuclear receptors orchestrate detoxification pathways. Dev Cell 4:607–608.
  • Rybczynski, R., Reagan, J., Lerner, M. R. (1989). A pheromone-degrading aldehyde oxidase in the antennae of the moth, Manduca sexta. J Neurosci 9:1341–1353.
  • Sabolovic, N., Heurtaux, T., Humbert, A. C., Krisa, S., Magdalou, J. (2007). cis- and trans-resveratrol are glucuronidated in rat brain, olfactory mucosa, and cultured astrocytes. Pharmacology 80:185–192.
  • Saeki, M., Ozawa, S., Saito, Y., Jinno, H., Hamaguchi, T., Nokihara, H., et al. (2002). Three novel single nucleotide polymorphisms in UGT1A10. Drug Metab Pharmacokinet 17:488–490.
  • Saeki, M., Saito, Y., Jinno, H., Sai, K., Komamura, K., Ueno, K., et al. (2003). Three novel single nucleotide polymorphisms in UGT1A9. Drug Metab Pharmacokinet 18:146–149.
  • Samokyszyn, V. M., Gall, W. E., Zawada, G., Freyaldenhoven, M. A., Chen, G., Mackenzie, P. I., et al. (2000). 4-hydroxyretinoic acid, a novel substrate for human liver microsomal UDP-glucuronosyltransferase(s) and recombinant UGT2B7. J Biol Chem 275:6908–6914.
  • Santa Maria, C., Machado, A. (1988). Changes in some hepatic enzyme activities related to phase II drug metabolism in male and female rats as a function of age. Mech Ageing Dev 44:115–125.
  • Scheff, S. W., Price, D. A., Schmitt, F. A. and Mufson, E. J. (2006). Hippocampal synaptic loss in early Alzheimer’s disease and mild cognitive impairment. Neurobiol Aging. 27:1372–1384.
  • Shelby, M. K., Cherrington, N. J., Vansell, N. R., Klaassen, C. D. (2003). Tissue mRNA expression of the rat UDP-glucuronosyltransferase gene family. Drug Metab Dispos 31:326–333.
  • Shepherd, G. M. (2004). The human sense of smell: are we better than we think? PLoS Biol 2:E146.
  • Shepherd, G. M. (2007). Perspectives on olfactory processing, conscious perception, and orbitofrontal cortex. Ann N Y Acad Sci 1121:87–101.
  • Stakhiv, T. M., Mesia-Vela, S., Kauffman, F. C. (2006). Phase II antioxidant enzyme activities in brain of male and female ACI rats treated chronically with estradiol. Brain Res 1104:80–91.
  • Sten, T., Bichlmaier, I., Kuuranne, T., Leinonen, A., Yli-Kauhaluoma, J., Finel, M. (2009). UDP-glucuronosyltransferases (UGTs) 2B7 and UGT2B17 display converse specificity in testosterone and epitestosterone glucuronidation, whereas UGT2A1 conjugates both androgens similarly. Drug Metab Dispos 37:417–423.
  • Strassburg, C. P., Strassburg, A., Kneip, S., Barut, A., Tukey, R. H., Rodeck, B., et al. (2002a). Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut 50:259–265.
  • Strassburg, C. P., Vogel, A., Kneip, S., Tukey, R. H., Manns, M. P. (2002b). Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer. Gut 50:851–856.
  • Sugatani, J., Sueyoshi, T., Negishi, M., Miwa, M. (2005). Regulation of the human UGT1A1 gene by nuclear receptors constitutive active/androstane receptor, pregnane × receptor, and glucocorticoid receptor. Meth Enzymol 400:92–104.
  • Suleman, F. G., Abid, A., Gradinaru, D., Daval, J. L., Magdalou, J., Minn, A. (1998). Identification of the uridine diphosphate glucuronosyltransferase isoform UGT1A6 in rat brain and in primary cultures of neurons and astrocytes. Arch Biochem Biophys 358:63–67.
  • Suleman, F. G., Ghersi-Egea, J. F., Leininger-Muller, B., Minn, A. (1993). Uridine diphosphate-glucuronosyltransferase activities in rat brain microsomes. Neurosci Lett 161:219–222.
  • Sullivan, J. M., Benton, J. L., Beltz, B. S. (2000). Serotonin depletion in vivo inhibits the branching of olfactory projection neurons in the lobster deutocerebrum. J Neurosci 20:7716–7721.
  • Sunkin, S. M., Hohmann, J. G. (2007). Insights from spatially mapped gene expression in the mouse brain. Hum Mol Genet 16(Spec No. 2):R209–R219.
  • Takeda, S., Ishii, Y., Iwanaga, M., Nurrochmad, A., Ito, Y., Mackenzie, P. I., et al. (2009). Interaction of cytochrome P450 3A4 and UDP-glucuronosyltransferase 2B7: evidence for protein-protein association and possible involvement of CYP3A4 J-helix in the interaction. Mol Pharmacol 75:956–964.
  • Tamura, H. O., Harada, Y., Miyawaki, A., Mikoshiba, K., Matsui, M. (1998). Molecular cloning and expression of a cDNA encoding an olfactory-specific mouse phenol sulphotransferase. Biochem J 331(Pt 3):953–958.
  • Tassoni, D., Kaur, G., Weisinger, R. S., Sinclair, A. J. (2008). The role of eicosanoids in the brain. Asia Pac J Clin Nutr 17(Suppl 1):220–228.
  • Terasaki, T., Pardridge, W. M. (2000). Targeted drug delivery to the brain; (blood-brain barrier, efflux, endothelium, biological transport). J Drug Target 8:353–355.
  • Thierry-Mieg, D., Thierry-Mieg, J. (2006). AceView: a comprehensive cDNA-supported gene and transcripts annotation. Genome Biol 7(Suppl 1):S12. 11–14. [Epub 2006 Aug 7].
  • Thum, T., Erpenbeck, V. J., Moeller, J., Hohlfeld, J. M., Krug, N., Borlak, J. (2006). Expression of xenobiotic metabolizing enzymes in different lung compartments of smokers and nonsmokers. Environ Health Perspect 114:1655–1661.
  • Tin Tin Win, S., Mitsushima, D., Yamamoto, S., Fukushima, A., Funabashi, T., Kobayashi, T., et al. (2008). Changes in neurotransmitter levels and proinflammatory cytokine mRNA expressions in the mice olfactory bulb following nanoparticle exposure. Toxicol Appl Pharmacol 226:192–198.
  • Tukey, R. H., Strassburg, C. P. (2000). Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40:581–616.
  • Turgeon, D., Chouinard, S., Belanger, P., Picard, S., Labbe, J. F., Borgeat, P., et al. (2003). Glucuronidation of arachidonic and linoleic acid metabolites by human UDP-glucuronosyltransferases. J Lipid Res 44:1182–1191.
  • Turman, C. M., Hatley, J. M., Ryder, D. J., Ravindranath, V., Strobel, H. W. (2006). Alternative splicing within the human cytochrome P450 superfamily with an emphasis on the brain: the convolution continues. Exp Opin Drug Metab Toxicol 2:399–418.
  • Upadhyay, U. D., Holbrook, E. H. (2004). Olfactory loss as a result of toxic exposure. Otolaryngol Clin North Am 37:1185–1207.
  • Verreault, M., Senekeo-Effenberger, K., Trottier, J., Bonzo, J. A., Belanger, J., Kaeding, J., et al. (2006). The liver X-receptor alpha controls hepatic expression of the human bile acid-glucuronidating UGT1A3 enzyme in human cells and transgenic mice. Hepatology 44:368–378.
  • Vessey, D. A., Zakim, D. (1974). Membrane fluidity and the regulation of membrane-bound enzymes. Horiz Biochem Biophys 1:138–174.
  • Viani, A., Temellini, A., Tusini, G., Pacifici, G. M. (1990). Human brain sulphotransferase and glucuronyltransferase. Hum Exp Toxicol 9:65–69.
  • Villeneuve, L., Girard, H., Fortier, L. C., Gagne, J. F., Guillemette, C. (2003). Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs. J Pharmacol Exp Ther 307:117–128.
  • Vogel, A., Kneip, S., Barut, A., Ehmer, U., Tukey, R. H., Manns, M. P., et al. (2001). Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene. Gastroenterology 121:1136–1144.
  • Wahlstrom, A., Hammar, L., Lundin, L. G., Rane, A. (1986). Morphine metabolism in mouse brain. NIDA Res Monogr 75:603–606.
  • Wahlstrom, A., Lundin, L. G., Ask, B., Rane, A. (1989). The sensitivity to noxious heat in relation to brain and liver opioid glucuronidation in inbred strains of mice. Pain 38:71–75.
  • Wahlstrom, A., Winblad, B., Bixo, M., Rane, A. (1988). Human brain metabolism of morphine and naloxone. Pain 35:121–127.
  • Wang, Q., Hasan, G., Pikielny, C. W. (1999). Preferential expression of biotransformation enzymes in the olfactory organs of Drosophila melanogaster, the antennae. J Biol Chem 274:10309–10315.
  • Wang, R. Y. (1988). Cholecystokinin, dopamine, and schizophrenia: recent progress and current problems. Ann N Y Acad Sci 537:362–379.
  • Wang, T. W., Zhang, H., Parent, J. M. (2005). Retinoic acid regulates postnatal neurogenesis in the murine subventricular zone-olfactory bulb pathway. Development 132:2721–2732.
  • Whitby-Logan, G. K., Weech, M., Walters, E. (2004). Zonal expression and activity of glutathione S-transferase enzymes in the mouse olfactory mucosa. Brain Res 995:151–157.
  • Winner, B., Cooper-Kuhn, C. M., Aigner, R., Winkler, J., Kuhn, H. G. (2002). Long-term survival and cell death of newly generated neurons in the adult rat olfactory bulb. Eur J Neurosci 16:1681–1689.
  • Winner, B., Geyer, M., Couillard-Despres, S., Aigner, R., Bogdahn, U., Aigner, L., et al. (2006). Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb. Exp Neurol 197:113–121.
  • Wishart, D. S., Knox, C., Guo, A. C., Eisner, R., Young, N., Gautam, B., et al. (2009). HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 37:D603–D610.
  • Wojtasek, H., Leal, W. S. (1999). Degradation of an alkaloid pheromone from the pale-brown chafer, Phyllopertha diversa (Coleoptera: Scarabaeidae), by an insect olfactory cytochrome P450. FEBS Lett 458:333–336.
  • Yamada, H., Ishii, K., Ishii, Y., Ieiri, I., Nishio, S., Morioka, T., et al. (2003). Formation of highly analgesic morphine-6-glucuronide following physiologic concentration of morphine in human brain. J Toxicol Sci 28:395–401.
  • Yamamoto, S., Oka, S., Saito-Ohara, F., Inazawa, J., Kawasaki, T. (2002). Molecular cloning and genomic analysis of mouse glucuronyltransferase involved in biosynthesis of the HNK-1 epitope. J Biochem 131:337–347.
  • Zakim, K., Vessey, D. A. (1975). Regulation of microsomal enzymes by phospholipids. IX. Production of uniquely modified forms of microsomal UDP-glucuronyltransferase by treatment with phospholipase A and detergents. Biochim Biophys Acta 410:61–73.
  • Zhang, X., Zhang, Q. Y., Liu, D., Su, T., Weng, Y., Ling, G., et al. (2005). Expression of cytochrome p450 and other biotransformation genes in fetal and adult human nasal mucosa. Drug Metab Dispos 33:1423–1428.
  • Zhuo, X., Gu, J., Behr, M. J., Swiatek, P. J., Cui, H., Zhang, Q. Y., et al. (2004). Targeted disruption of the olfactory mucosa-specific Cyp2g1 gene: impact on acetaminophen toxicity in the lateral nasal gland, and tissue-selective effects on Cyp2a5 expression. J Pharmacol Exp Ther 308:719–728.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.